CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005) [Phase 1]
Summary
Phase 1 study of doravirine (MK-1439) in HIV-1-infected participants has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-02-15